Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy

Medical and Pediatric Oncology

Volumn 31, Issue 2, 1998, Pages 56-60

  Engel, B C ^a   Laws, H J ^a   Buttlies, B ^a   Kahn, T ^a   Gobel, U ^a   Burdach, S E G ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

CD3+ CD56+; Gene therapy; IL 2; Peripheral neuroectodermal malignancy

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 2;

ARTICLE; FIBROBLAST; GENE THERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; NEUROECTODERM TUMOR; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANTIGENS, CD3; ANTIGENS, CD56; CHILD; FIBROBLASTS; GENE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRALESIONAL; INTERLEUKIN-2; KILLER CELLS; MALE; NEUROECTODERMAL TUMORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031856390     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199808)31:2<56::AID-MPO2>3.0.CO;2-Y     Document Type: Article

References (17)